More Leeway For Reviewers In Updated 510(k) 'Refuse-To-Accept' Policy
This article was originally published in The Gray Sheet
Executive Summary
An updated 510(k) “refuse to accept” guidance document gives FDA staff more opportunity to work with sponsors to smooth out product submissions without repeatedly halting and restarting the review clock with RTA determinations.